Active for more than 60 years in the production of pharmaceutical APIs in the regulated markets worldwide, Infa puts its long standing experience and know- how in providing superior Contract Manufacturing and Development Services to Pharma companies large and small. With its 3 European cGMP plants, Infa offers technologies also addressing read morehazardous chemistries: large scale brominations, chlorinations, cyanurations, oxydations, high pressure hydrogenations, reactions with sodium metal, cryogenic reactions and benzene handling. Additionally, the new multipurpose (no cytotoxic) GMP HPAPI small scale plant extends Infa’s capabilities